Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.430
-0.110 (-4.33%)
At close: Aug 28, 2026, 4:00 PM EDT
2.430
-0.001 (-0.02%)
After-hours: Aug 28, 2026, 7:48 PM EDT

Fate Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
32.4346.6336.0641.8761.33133.58
Short-Term Investments
121.34157.03243.01273.31374.89482.33
Cash & Short-Term Investments
153.77203.66279.07315.18436.23615.91
Cash Growth
-30.99%-27.02%-11.46%-27.75%-29.17%27.54%
Accounts Receivable
0.70.923.541.8338.488.68
Other Receivables
0.30.72.10.90.81.1
Receivables
11.625.642.7339.289.78
Prepaid Expenses
3.183.437.213.6426.577.73
Total Current Assets
157.95208.7291.91331.54502.07633.41
Property, Plant & Equipment
92.198.53110.89158.51176.09162.25
Long-Term Investments
-1.4727.660.984.94100.66
Long-Term Deferred Charges
----7.29.87
Other Long-Term Assets
10.0510.2310.2415.1915.2615.26
Total Assets
260.1318.94440.69506.22705.56921.46

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.262.669.374.728.278.61
Accrued Expenses
14.920.0221.3527.5153.9342.41
Current Portion of Leases
4.924.567.426.185.635.58
Current Unearned Revenue
-0.380.390.6942.2321.48
Other Current Liabilities
9.518.45--43.2
Total Current Liabilities
32.5936.0738.5239.09114.0581.28
Long-Term Leases
70.7573.2977.8597.36103.71109.24
Long-Term Unearned Revenue
-----27.12
Other Long-Term Liabilities
3.322.45.61.353.8624.97
Total Liabilities
106.67111.75121.97137.8221.62242.62

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.120.120.110.10.10.1
Additional Paid-In Capital
1,7491,7411,7161,5801,5361,449
Retained Earnings
-1,596-1,534-1,398-1,212-1,051-769.08
Comprehensive Income & Other
-0.120.120.270.02-1.85-0.76
Total Common Equity
153.44207.18318.72368.41483.94678.84
Shareholders' Equity
153.44207.18318.73368.42483.94678.84
Total Liabilities & Equity
260.1318.94440.69506.22705.56921.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
75.6877.8585.27103.54109.34114.82
Net Cash (Debt)
78.1125.81193.8211.64326.89501.09
Net Cash Growth
-44.81%-35.09%-8.43%-35.26%-34.77%29.95%
Net Cash Per Share
0.651.061.702.153.385.29
Filing Date Shares Outstanding
119.82116.26114.699.2498.1696.43
Total Common Shares Outstanding
116.69115.36113.9398.6397.2995.73
Working Capital
125.36172.63253.39292.45388.02552.13
Book Value Per Share
1.311.802.803.744.977.09
Tangible Book Value
153.44207.18318.72368.41483.94678.84
Tangible Book Value Per Share
1.311.802.803.744.977.09
Machinery
-29.6138.8583.2981.553.63
Leasehold Improvements
-62.3659.4959.0456.7852.95
SEC Filings: 10-K · 10-Q